nach oben

Erschienen in:

30.09.2023 | Research Article

Characteristics of deceleration capacity and deceleration runs in vasovagal syncope

verfasst von: Jiakun Li, Wei Sun, Xu Yang, Bin Tu, Simin Cai, Feng Hu, Zhiyuan Weng, Shangyu Liu, Zihao Lai, Lihui Zheng, Yan Yao

Erschienen in: Clinical Autonomic Research | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Increased vagal activity plays a prominent role in vasovagal syncope (VVS). The aim of this study was to characterize vagal function in VVS by evaluating the heart rate (HR) deceleration capacity (DC) and the HR deceleration runs (DRs) in patients with VVS between attacks.

Methods

A total of 188 consecutive VVS patients were enrolled in the study, of whom 129 had positive head-up tilt test (HUTT); 132 healthy participants were enrolled as controls. DC, DRs (DR2, i.e., episodes of 2 consecutive beat-to-beat HR decelerations), and the sum of DR8-10 (very long DR [VLDR]) were calculated using 24-h electrograms. Clinical characteristics, DC, and DRs were compared among syncope groups and controls.

Results

Patients with VVS had higher DC (10.63 ± 2.1 vs. 6.58 ± 1.7 ms; P < 0.001) and lower minimum HR and DR6-10 than controls. No significant differences in DC or DR6-10 were found between the patients with positive and those with negative HUTT results. In multivariate logistic regression analysis, minimum HR ≥ 40 bpm (odds ratio [OR] 0.408, 95% confidence interval [CI] 0.167–0.989; P = 0.048), daytime DC ≥ 7.37 ms (OR 3.040, 95% CI 1.220–7.576; P = 0.013), and VLDR ≥ 0.046% (OR 0.306, 95% CI 0.138–0.679; P = 0.004) were demonstrated to be risk factors significantly associated with VVS.

Conclusion

Compared to healthy controls, patients with VVS demonstrated distinct HR deceleration profiles between attacks, including overall higher DC and lower DR6-10.

Nur mit Berechtigung zugänglich

Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A et al (2018) 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J 39(21):1883–1948. https://doi.org/10.1093/eurheartj/ehy037CrossRefPubMed

Malasana G, Brignole M, Daccarett M, Sherwood R, Hamdan MH (2011) The prevalence and cost of the faint and fall problem in the state of Utah. Pacing Clin Electrophysiol 34(3):278–283. https://doi.org/10.1111/j.1540-8159.2010.02930.xCrossRefPubMed

Van Dijk N, Quartieri F, Blanc JJ, Garcia-Civera R, Brignole M, Moya A et al (2006) Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol 48(8):1652–1657. https://doi.org/10.1016/j.jacc.2006.06.059CrossRefPubMed

Van Dijk JG, van Rossum IA, Thijs RD (2021) The pathophysiology of vasovagal syncope: novel insights. Auton Neurosci. 236:102899. https://doi.org/10.1016/j.autneu.2021.102899CrossRefPubMed

Jardine DL, Wieling W, Brignole M, Lenders JWM, Sutton R, Stewart J (2018) The pathophysiology of the vasovagal response. Heart Rhythm 15(6):921–929. https://doi.org/10.1016/j.hrthm.2017.12.013CrossRefPubMed

Wieling W, Jardine DL, de Lange FJ, Brignole M, Nielsen HB, Stewart J et al (2016) Cardiac output and vasodilation in the vasovagal response: an analysis of the classic papers. Heart Rhythm 13(3):798–805. https://doi.org/10.1016/j.hrthm.2015.11.023CrossRefPubMed

van Dijk JG, Ghariq M, Kerkhof FI, Reijntjes R, van Houwelingen MJ, van Rossum IA et al (2020) Novel methods for quantification of vasodepression and cardioinhibition during tilt-induced vasovagal syncope. Circ Res 127(5):e126–e138. https://doi.org/10.1161/circresaha.120.316662CrossRefPubMed

Virag N, Erickson M, Taraborrelli P, Vetter R, Lim PB, Sutton R (2018) Predicting vasovagal syncope from heart rate and blood pressure: a prospective study in 140 subjects. Heart Rhythm 15(9):1404–1410. https://doi.org/10.1016/j.hrthm.2018.04.032CrossRefPubMed

Tellez MJ, Norcliffe-Kaufmann LJ, Lenina S, Voustianiouk A, Kaufmann H (2009) Usefulness of tilt-induced heart rate changes in the differential diagnosis of vasovagal syncope and chronic autonomic failure. Clin Auton Res 19(6):375–380. https://doi.org/10.1007/s10286-009-0039-9CrossRefPubMed

10.

Tu B, Wu L, Hu F, Fan S, Liu S, Liu L et al (2022) Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope. Heart Rhythm 19(4):562–569. https://doi.org/10.1016/j.hrthm.2021.12.007CrossRefPubMed

11.

Guzik P, Piskorski J, Barthel P, Bauer A, Muller A, Junk N et al (2012) Heart rate deceleration runs for postinfarction risk prediction. J Electrocardiol 45(1):70–76. https://doi.org/10.1016/j.jelectrocard.2011.08.006CrossRefPubMed

12.

Jiang J, Chen X, Zhang C, Wang G, Fang J, Ma J et al (2017) Heart rate acceleration runs and deceleration runs in patients with obstructive sleep apnea syndrome. Sleep Breath 21(2):443–451. https://doi.org/10.1007/s11325-016-1437-6CrossRefPubMed

13.

Kong Z, Wang X, Shen S, Liu H, Chen B, Chen Z et al (2020) Risk prediction for arrhythmias by heart rate deceleration runs in patients with chronic obstructive pulmonary disease. Int J Chron Obstruc Pulmon Dis. 17(15):585–593. https://doi.org/10.2147/COPD.S234470CrossRef

14.

Sheldon RS, Grubb BP 2nd, Olshansky B, Shen WK, Calkins H, Brignole M et al (2015) 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 12(6):e41-63. https://doi.org/10.1016/j.hrthm.2015.03.029CrossRefPubMedPubMedCentral

15.

Sutton R, Brignole M (2014) Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis. Eur Heart J 35(33):2211–2212. https://doi.org/10.1093/eurheartj/ehu255CrossRefPubMed

16.

Bauer A, Kantelhardt JW, Barthel P, Schneider R, Mäkikallio T, Ulm K et al (2006) Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. The Lancet 367(9523):1674–1681CrossRef

17.

Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17(3):354–81CrossRef

18.

Tahvanainen A, Koskela J, Leskinen M, Ilveskoski E, Nordhausen K, Kahonen M et al (2011) Reduced systemic vascular resistance in healthy volunteers with presyncopal symptoms during a nitrate-stimulated tilt-table test. Br J Clin Pharmacol 71(1):41–51. https://doi.org/10.1111/j.1365-2125.2010.03794.xCrossRefPubMedPubMedCentral

19.

Lagi A, Cencetti S, Cartei A (2011) What happens before syncope? Study of the time frame preceding vasovagal syncope. ISRN Cardiol 2011:659787. https://doi.org/10.5402/2011/659787CrossRefPubMedPubMedCentral

20.

Sun W, Zheng L, Qiao Y, Shi R, Hou B, Wu L et al (2016) Catheter ablation as a treatment for vasovagal syncope: long-term outcome of endocardial autonomic modification of the left atrium. J Am Heart Assoc. 5(7):e003471. https://doi.org/10.1161/jaha.116.003471CrossRefPubMedPubMedCentral

21.

Piccirillo G, Naso C, Moisè A, Lionetti M, Nocco M, Di Carlo S et al (2004) Heart rate and blood pressure variability in subjects with vasovagal syncope. Clin Sci (London) 107(1):55–61. https://doi.org/10.1042/cs20030327CrossRef

22.

Alehan D, Ayabakan C, Ozer S (2002) Heart rate variability and autonomic nervous system changes in children with vasovagal syncope. Pacing Clin Electrophysiol 25(9):1331–1338. https://doi.org/10.1046/j.1460-9592.2002.01331.xCrossRefPubMed

23.

Sammito S, Böckelmann I (2016) Factors influencing heart rate variability. Int Cardiovasc Forum J 6:18–22. https://doi.org/10.17987/icfj.v6i0.242CrossRef

24.

Duckheim M, Klee K, Götz N, Helle P, Groga-Bada P, Mizera L et al (2017) Deceleration capacity as a risk predictor in patients presenting to the emergency department with syncope: A prospective exploratory pilot study. Medicine (Baltimore) 96(49):e8605. https://doi.org/10.1097/MD.0000000000008605CrossRefPubMed

25.

van Dijk JG, van Rossum IA, van Houwelingen M, Ghariq M, Saal DP, de Lange FJ et al (2022) Influence of age on magnitude and timing of vasodepression and cardioinhibition in tilt-induced vasovagal syncope. JACC Clin Electrophysiol 8(8):997–1009. https://doi.org/10.1016/j.jacep.2022.05.009CrossRefPubMed

Titel: Characteristics of deceleration capacity and deceleration runs in vasovagal syncope
verfasst von: Jiakun Li
Wei Sun
Xu Yang
Bin Tu
Simin Cai
Feng Hu
Zhiyuan Weng
Shangyu Liu
Zihao Lai
Lihui Zheng
Yan Yao
Publikationsdatum: 30.09.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Autonomic Research / Ausgabe 1/2024
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI: https://doi.org/10.1007/s10286-023-00989-z

Neu in den Fachgebieten Neurologie und Psychiatrie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Characteristics of deceleration capacity and deceleration runs in vasovagal syncope